ESCMID Study Group for Respiratory viruses  – ESGREV

 

ESGREV Annual Report

Download the latest Annual Report.

 

News & Activities

2022 Annual Report Published

The Annual Report showcasing the achievements of the previous year is now available to view. Be sure to check out the report to see what the Study Group was able to accomplish in 2022 as well as what they plan for the future.

 

ESGREV newsletter published for July 2022

The ESGREV Newsletter for July 2022 has just been published online. Inside you can find a message from the ESGREV Executive Committee and updates on membership, research projects, publications and more. Be sure to read up today!

 

New ESGREV Executive Committee elected

A new ESGREV Executive Committee has been elected and will now be:

 

  • Chrysanthi Skevaki, Germany
  • Roy Chemaly, United States
  • Barbara Rath, France
  • Sotirios Tsiodras, Greece
  • Louis Bont, Netherlands

 

We thank all previous Executive Committee for their excellent work over the last years. We are looking forward to continuing this work.

 

You can find the full election report here

 

2021 Annual Report Published

The Annual Report showcasing the achievements of the previous year is now available to view. Be sure to check out the report to see what the Study Group was able to accomplish in 2021 as well as what they plan for the future.

ESGREV Webinar: Respiratory viral infections in distinct patient populations in the era of the COVID-19 pandemic

Tuesday, 14 December 2021, 14:00 - 17:30 CET
 

Register for the webinar here (free of charge)
 

Chairs: Chrysanthi Skevaki, Roy Chemaly

Presentations:

Time (CET)

Title

First Name

Last Name

City, Country

14.00-14:30

Respiratory viruses and the elderly patient population

Sotirios

Tsiodras

Athens, Greece

14:30-15:00

Are Asthmatic individuals at risk?

Chrysanthi

Skevaki

Marburg & Giessen, Germany

15:00-15:30

Respiratory viruses in patients with COPD

Sebastian
 

Johnston
 

London, UK

15:30-16:00

Impact of COVID-19 on circulating respiratory viruses in immunocompromised patients

Roy

Chemaly

Houston, Texas, US

16:00-16:30

Outcomes of respiratory viruses in ICU patients

David

Ong

Rotterdam, Netherlands

16:30-17:00

Respiratory viruses and the pulmonary vasculature - Focus on COVID-19

Natascha

Sommer

Giessen, Germany

17:00-17:30

What we learned so far about respiratory viruses including coronaviruses in children?

Barbara

Rath

Besancon, France and Berlin, Germany

 

 

2020 Annual Report Published

The Annual Report showcasing the achievements of the previous year is now available to view. 2020 was a challenging year due to COVID-19, but check out the report to see what the Study Group was able to accomplish or plan for the future.

New ESGREV Executive Committee elected

A new ESGREV Executive Committee has been elected and will now be:

  • Chrysanthi Skevaki, Germany
  • Roy Chemaly, United States
  • Barbara Rath, France
  • Sotirios Tsiodras, Greece
  • David Ong, Netherlands

We thank all previous Executive Committee for their excellent work over the last years. We are looking forward to continuing this work.

You can find the full election report here

Survey on Point of Care testing (POCT)

May 9, 2019

The Executive Committee of ESCMID Study Group for Respiratory Viruses would like to invite ESCMID members to respond to the “Survey on Point of Care testing (POCT) for seasonal influenza and other respiratory viruses”. This survey aims to capture the current status of use of point of care testing in the ESCMID community and to highlight areas of best practice and areas where further work is required. Please fill in the survey by following this link:

https://www.surveymonkey.co.uk/r/ESGREVsurvey

Please feel free to share this survey with your colleagues; that would substantially help collect solid data from Europe and beyond.